Iovance Biotherapeutics, Inc. (IOVA) Revenue by Year
Iovance Biotherapeutics, Inc. generated $263.5M in revenue in fiscal year 2025. This represents an increase of 60.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $325.0M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Iovance Biotherapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IOVA Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
IOVA Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Iovance Biotherapeutics, Inc. financials
Frequently Asked Questions
What was Iovance Biotherapeutics, Inc.'s revenue in fiscal year 2025?
Iovance Biotherapeutics, Inc. generated $263.5M in revenue in fiscal year 2025.
How fast is Iovance Biotherapeutics, Inc.'s revenue growing?
Iovance Biotherapeutics, Inc. (IOVA) revenue rose by 60.6% year over year, from $164.1M to $263.5M in fiscal year 2025.
What is Iovance Biotherapeutics, Inc.'s revenue over the last twelve months?
Iovance Biotherapeutics, Inc. (IOVA) reported $325.0M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Iovance Biotherapeutics, Inc.'s revenue changed over the years?
Across the 15 fiscal years this page covers, Iovance Biotherapeutics, Inc. (IOVA) revenue went from $0 in fiscal year 2011 to $263.5M in fiscal year 2025.
What was Iovance Biotherapeutics, Inc.'s revenue in the most recent quarter?
Iovance Biotherapeutics, Inc. (IOVA) reported $99.3M in revenue in Q2 2026. This represents an increase of 65.7% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Iovance Biotherapeutics, Inc. (IOVA) reported on that line in every period on record.